The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 14, 2024

Filed:

Jan. 15, 2021
Applicant:

Pharmazell Gmbh, Raubling, DE;

Inventors:

Dirk Weuster-Botz, Munich, DE;

Michael Braun, Bad Mergentheim-Edelfingen, DE;

Arno Aigner, Tuntenhausen, DE;

Boqiao Sun, Munich, DE;

Christina Kantzow, Munich, DE;

Sven Bresch, Munich, DE;

Daniel Bakonyi, Cologne, DE;

Werner Hummel, Titz, DE;

Assignee:

Pharmazell GmbH, Raubling, DE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12P 33/00 (2006.01); C12N 9/00 (2006.01); C12N 9/02 (2006.01); C12N 9/04 (2006.01); C12P 33/02 (2006.01);
U.S. Cl.
CPC ...
C12N 9/0006 (2013.01); C12N 9/0008 (2013.01); C12P 33/00 (2013.01); C12P 33/02 (2013.01); C12Y 101/01201 (2013.01);
Abstract

In various aspects and embodiments, the invention provides a nucleic acid molecule comprising a nucleotide sequence encoding a 7β-hydroxysteroid dehydrogenase (7β-HSDH) mutant that catalyzes at least the stereospecific enzymatic reduction of a 7-ketosteroid to the corresponding 7-hydroxysteroid, wherein the mutant has, compared to the wildtype 7β-HSDH of SEQ ID NO:2, a decreased substrate inhibition and/or an altered cofactor usage, and the mutant has, in comparison with the wildtype 7β-HSDH of SEQ ID NO:2, 1 to 15 amino acid additions, substitutions, deletions and/or inversions in the sequence motif VMVGRRE corresponding to positions 36 to 42 of SEQ ID NO:2.


Find Patent Forward Citations

Loading…